Healthcare provider profile · identity verified

Brian David Devine, MD

Family Practice · CHARLOTTE, NC · NPI 1518946540

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	476	144
Atorvastatin Calcium	Atorvastatin Calcium	389	115
Lisinopril	Lisinopril	234	69
Losartan Potassium	Losartan Potassium	233	68
Gabapentin	Gabapentin	207	69
Levothyroxine Sodium	Levothyroxine Sodium	199	62
Rosuvastatin Calcium	Rosuvastatin Calcium	189	56
Metformin Hcl Er	Metformin Hcl	188	57
Pantoprazole Sodium	Pantoprazole Sodium	171	64
Metformin Hcl	Metformin Hcl	152	46
Hydrochlorothiazide	Hydrochlorothiazide	127	45
Escitalopram Oxalate	Escitalopram Oxalate	122	35
Montelukast Sodium	Montelukast Sodium	113	34
Tamsulosin Hcl	Tamsulosin Hcl	112	37
Omeprazole	Omeprazole	107	43
Simvastatin	Simvastatin	107	33
Carvedilol	Carvedilol	106	36
Ozempic	Semaglutide	104	24
Albuterol Sulfate Hfa	Albuterol Sulfate	98	36
Metoprolol Succinate	Metoprolol Succinate	97	33
Meloxicam	Meloxicam	96	49
Furosemide	Furosemide	94	34
Trazodone Hcl	Trazodone Hcl	92	37
Clopidogrel	Clopidogrel Bisulfate	78	24
Fluticasone Propionate	Fluticasone Propionate	78	42
Pravastatin Sodium	Pravastatin Sodium	77	21
Sertraline Hcl	Sertraline Hcl	77	29
Jardiance	Empagliflozin	75	18
Duloxetine Hcl	Duloxetine Hcl	73	18
Metoprolol Tartrate	Metoprolol Tartrate	72	28
Allopurinol	Allopurinol	69	23
Alprazolam	Alprazolam	68	16
Bupropion Xl	Bupropion Hcl	60	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	19
Eliquis	Apixaban	53	15
Glimepiride	Glimepiride	53	15
Potassium Chloride	Potassium Chloride	48	16
Triamcinolone Acetonide	Triamcinolone Acetonide	48	33
Famotidine	Famotidine	45	15
Finasteride	Finasteride	45	14
Lorazepam	Lorazepam	45	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	suppressed
Clonazepam	Clonazepam	37	suppressed
Donepezil Hcl	Donepezil Hcl	37	11
Spironolactone	Spironolactone	37	13
Alendronate Sodium	Alendronate Sodium	36	13
Mirtazapine	Mirtazapine	36	11
Promethazine Hcl	Promethazine Hcl	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	11
Tramadol Hcl	Tramadol Hcl	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	11
Celecoxib	Celecoxib	29	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	11
Ramipril	Ramipril	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Cephalexin	Cephalexin	27	20
Valsartan	Valsartan	27	suppressed
Prednisone	Prednisone	26	16
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	21
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Torsemide	Torsemide	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Methylprednisolone	Methylprednisolone	23	19
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Amoxicillin	Amoxicillin	22	21
Mometasone Furoate	Mometasone Furoate	22	suppressed
Naratriptan Hcl	Naratriptan Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Cefdinir	Cefdinir	21	21
Farxiga	Dapagliflozin Propanediol	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Ketoconazole	Ketoconazole	20	11
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Novolog Flexpen	Insulin Aspart	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Azithromycin	Azithromycin	13	13
Ibuprofen	Ibuprofen	13	suppressed
Linzess	Linaclotide	13	suppressed
Naproxen	Naproxen	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Risperidone	Risperidone	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Atenolol	Atenolol	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Glipizide	Glipizide	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error